In summary, we highlight the important functions of YBX1 in IH and identified the potential downstream targets of YBX1, which can be used as candidate therapeutic targets for IH and other cardiovascular diseases in the future. This evidence concerns the gene YBX1 and isolated hemihyperplasia.